In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA

Antiviral Research

Volumn 75, Issue 1, 2007, Pages 52-57

  Dal Pozzo, Fabiana ^a,b   Andrei, Graciela ^a   Lebeau, Ilya ^a   Beadle, James R ^c   Hostetler, Karl Y ^c   De Clercq, Erik ^a   Snoeck, Robert ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b Alma Mater Studiorum ^*  (Italy)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Acyclic nucleoside phosphonates; Contagious ecthyma; Oral bioavailability; Orf virus; Prodrugs

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACYCLIC NUCLEOSIDE; ACYCLIC NUCLEOSIDE PHOSPHONATE; CIDOFOVIR; ESTER DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SELECTIVITY; ECTHYMA; EMBRYO; HUMAN; HUMAN CELL; KERATINOCYTE; LUNG FIBROBLAST; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; VIRUS ISOLATION;

ADENINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTOSINE; ECTHYMA, CONTAGIOUS; FIBROBLASTS; HUMANS; KERATINOCYTES; LUNG; NUCLEOSIDES; ORF VIRUS; PHOSPHONIC ACIDS; PRODRUGS; SENSITIVITY AND SPECIFICITY; SHEEP;

CAPRA HIRCUS; ORF VIRUS; OVIS ARIES; PARAPOXVIRUS;

EID: 34247197683     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.11.010     Document Type: Article

References (39)

1. Agger W.A., and Webster S.B. Human orf infection complicated by erythema multiforme. Cutis 31 (1983) 334-338
2. Andrei G., De Clercq E., and Snoeck R. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?. Antiviral Res. 61 (2004) 181-187
3. Ballanger F., Barbarot S., Mollat C., Bossard C., Cassagnau E., Renac F., and Stalder J.F. Two giant orf lesions in a heart/lung transplant patient. Eur. J. Dermatol. 16 (2006) 284-286
4. Beadle J.R., Hartline C., Aldern K.A., Rodriguez N., Harden E., Kern E.R., and Hostetler K.Y. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Antimicrob. Agents Chemother. 46 (2002) 2381-2386
5. Bodnar M.G., Miller III O.F., and Tyler W.B. Facial orf. J. Am. Acad. Dermatol. 40 (1999) 815-817
6. Buller R.M., Owens G., Schriewer J., Melman L., Beadle J.R., and Hostetler K.Y. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Virology 318 (2004) 474-481
7. Chahidi N., de Fontaine S., and Lacotte B. Human orf. Br. J. Plast. Surg. 46 (1993) 532-534
8. Ciesla S.L., Trahan J., Wan W.B., Beadle J.R., Aldern K.A., Painter G.R., and Hostetler K.Y. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antiviral Res. 59 (2003) 163-171
9. Dal Pozzo F., Andrei G., Holý A., Van den Oord J., Scagliarini A., De Clercq E., and Snoeck R. Activity of acyclic nucleoside phosphonates against orf virus in human and ovine cell monolayers and organotypic ovine raft cultures. Antimicrob. Agents Chemother. 49 (2005) 4843-4852
10. Degraeve C., De Coninck A., Senneseael J., and Roseeuw D. Recurrent contagious ecthyma (Orf) in an immunocompromised host successfully treated with cryotherapy. Dermatology 198 (1999) 162-163
11. Dupré A., Christol B., Bonafe J.L., and Lassere J. Orf and atopic dermatitis. Br. J. Dermatol. 105 (1981) 103-104
12. Geerinck K., Lukito G., Snoeck R., De Vos R., De Clercq E., Vanrenterghem Y., Degreef H., and Maes B. A case of human orf in an immunocompromised patient successfully treated with cidofovir cream. J. Med. Virol. 64 (2001) 543-549
13. Groves R., MacDonald D.M., and Jones E.W. Human orf. Arch. Dermatol. 126 (1990) 1649
14. Gunduz K., Inanir I., and Sacar T. Orf and religious practices. J. Dermatol. 32 (2005) 306-308
15. Gurel M.S., Ozardali I., Bitiren M., San I., and Zeren H. Giant orf on the nose. Eur. J. Dermatol. 12 (2002) 183-185
16. Haig D.M., and Mercer A.A. Ovine diseases. Orf Vet. Res. 29 (1998) 311-326
17. Hansen E., Nyfors A., Naess A., and Sjursen H. Erythema multiforme major (Stevens-Johnson syndrome) caused by orf virus infection. Tidsskr. Nor. Laegeforen. 104 (1984) 978-979
18. Hartline C.B., Gustin K.M., Wan W.B., Ciesla S.L., Beadle J.R., Hostetler K.Y., and Kern E.R. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J. Infect. Dis. 191 (2005) 396-399
19. Hunskaar S. A case of ecthyma contagiusum (human orf) treated with idoxuridine. Dermatologica 168 (1984) 207
20. Hunskaar S. Giant orf in a patient with chronic lymphocytic leukaemia. Br. J. Dermatol. 114 (1986) 631-634
21. Keith K.A., Wan W.B., Ciesla S.L., Beadle J.R., Hostetler K.Y., and Kern E.R. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro. Antimicrob. Agents Chemother. 48 (2004) 1869-1871
22. Kern E.R., Hartline C., Harden E., Keith K., Rodriguez N., Beadle J.R., and Hostetler K.Y. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob. Agents Chemother. 46 (2002) 991-995
23. Koonsaeng S., Verschraegen C., Freedman R., Bossens M., Kudelka A., Kavanagh J., Sittisomwong T., De Clercq E., and Snoeck R. Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir. J. Med. Virol. 64 (2001) 195-198
24. Leavell Jr. U.W., McNamara M.J., Muelling R., Talbert W.M., Rucker R.C., and Dalton A.J. Orf. report of 19 human cases with clinical and pathological observations. JAMA 203 (1968) 657-664
25. Lebeau I., Andrei G., Dal Pozzo F., Beadle J.R., Hostetler K.Y., De Clercq E., Van den Oord J., and Snoeck R. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures. Antimicrob. Agents Chemother. 50 (2006) 2525-2529
26. Mourtada I., Le Tourneur M., Chevrant-Breton J., and Le Galle F. Human orf and erythema multiforme. Ann. Dermatol. Venereol. 127 (2000) 397-399
27. Murphy J.K., and Ralfs I.G. Bullous pemphigoid complicating human orf. Br. J. Dermatol. 134 (1996) 929-930
28. Nettleton P.F., Gilray J.A., Reid H.W., and Mercer A.A. Parapoxviruses are strongly inhibited in vitro by cidofovir. Antiviral Res. 48 (2000) 205-208
29. Pether J.V., Guerrier C.J., Jones S.M., Adam A.E., and Kingsbury W.N. Giant orf in a normal individual. Br. J. Dermatol. 115 (1986) 497-499
30. Pontes P., Avelino M., Pignatari S., and Weckx L.L. Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis. Otolaryngol. Head Neck Surg. 135 (2006) 22-27
31. Quenelle D.C., Collins D.J., Wan W.B., Beadle J.R., Hostetler K.Y., and Kern E.R. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Antimicrob. Agents Chemother. 48 (2004) 404-412
32. Savage J., and Black M.M. Giant orf of finger in a patient with a lymphoma. Proc. R. Soc. Med. 65 (1972) 766-768
33. Scagliarini A., Dal Pozzo F., Gallina L., Guercio A., Vaccari F., Battilani M., Ciulli S., and Prosperi S. In vitro activity of VEGF-E produced by orf virus strains isolated from classical and persistent contagious ecthyma. Vet. Microbiol. 114 (2006) 142-147
34. Scagliarini A., McInnis C.J., Gallina L., Dal Pozzo F., Scagliarini L., Snoeck R., Prosperi S., Sales J., Gilray J.A., and Nettleton P.F. Antiviral activity of HPMPC (Cidofovir) against orf virus infected lambs. Antiviral Res. 73 (2007) 169-174
35. Snoeck R., Andrei G., Gerard M., Silverman A., Hedderman A., Balzarini J., Sadzot-Delvaux C., Tricot G., Clumeck N., and De Clercq E. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine (HPMPC). Clin. Infect. Dis. 18 (1994) 570-578
36. Tan S.T., Blake G.B., and Chambers S. Recurrent orf in an immunocompromised host. Br. J. Plast. Surg. 44 (1991) 465-467
37. Toro J.R., Wood L.V., Patel N.K., and Turner M.L. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch. Dermatol. 136 (2000) 983-985
38. Uzel M., Sasmaz S., Bakaris S., Cetinus E., Bilgic E., Karaoguz A., Ozkul A., and Arican O. A viral infection of the hand commonly seen after the feast of sacrifice: human orf (orf of the hand). Epidemiol. Infect. 133 (2005) 653-657
39. Uzel M., Sasmaz S., Ozkul A., Cetinus E., Bilgic E., and Karaoguz A. Swan-neck deformity and paresthesia following giant orf. J. Dermatol. 31 (2004) 116-118